Kate Maclagan

3.9k total citations · 3 hit papers
15 papers, 2.6k citations indexed

About

Kate Maclagan is a scholar working on Obstetrics and Gynecology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kate Maclagan has authored 15 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Obstetrics and Gynecology, 4 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kate Maclagan's work include Pregnancy and preeclampsia studies (6 papers), Diabetes Treatment and Management (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Kate Maclagan is often cited by papers focused on Pregnancy and preeclampsia studies (6 papers), Diabetes Treatment and Management (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Kate Maclagan collaborates with scholars based in United Kingdom, Spain and Italy. Kate Maclagan's co-authors include D. Janga, Mandeep Singh, S. Cicero, Argyro Syngelaki, Ranjit Akolekar, K. H. Nicolaides, Liona C. Poon, Jacques Jani, D. Wright and C. de Paco Matallana and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Kate Maclagan

15 papers receiving 2.5k citations

Hit Papers

Aspirin versus Placebo in Pregnancies at High Risk for Pr... 2017 2026 2020 2023 2017 2017 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
    2017 1.4k citations Daniel L. Rolnik, D. Wright et al. New England Journal of Medicine profile →
  2. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    2017 603 citations Dilan Athauda, Kate Maclagan et al. The Lancet profile →
  3. Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
    2018 251 citations Min Yi Tan, D. Wright et al. Ultrasound in Obstetrics and Gynecology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Maclagan United Kingdom 11 1.6k 1.3k 407 326 315 15 2.6k
Bjarne M. Iversen Norway 22 719 0.5× 715 0.6× 22 0.1× 235 0.7× 167 0.5× 76 2.0k
Florian Herse Germany 34 2.3k 1.5× 1.6k 1.3× 17 0.0× 346 1.1× 180 0.6× 99 3.3k
Jean St‐Louis Canada 26 512 0.3× 451 0.4× 19 0.0× 170 0.5× 206 0.7× 99 2.4k
Chatarina Löfqvist Sweden 38 154 0.1× 2.3k 1.8× 44 0.1× 128 0.4× 447 1.4× 85 4.9k
C.‐H. Bergh Sweden 17 122 0.1× 515 0.4× 100 0.2× 313 1.0× 153 0.5× 26 2.0k
Francisco Westermeier Chile 20 420 0.3× 253 0.2× 54 0.1× 29 0.1× 93 0.3× 42 1.1k
Rainer Rossi Germany 16 142 0.1× 333 0.3× 90 0.2× 129 0.4× 42 0.1× 41 1.3k
Diva D. De León United States 35 127 0.1× 464 0.4× 286 0.7× 36 0.1× 2.4k 7.7× 121 3.9k
W M Wiersinga Netherlands 25 107 0.1× 173 0.1× 100 0.2× 75 0.2× 1.2k 3.9× 72 1.8k

Countries citing papers authored by Kate Maclagan

Since Specialization
Citations

This map shows the geographic impact of Kate Maclagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Maclagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Maclagan more than expected).

Fields of papers citing papers by Kate Maclagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Maclagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Maclagan. The network helps show where Kate Maclagan may publish in the future.

Co-authorship network of co-authors of Kate Maclagan

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Maclagan. A scholar is included among the top collaborators of Kate Maclagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Maclagan. Kate Maclagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Syngelaki, Argyro, Anca Marina Ciobanu, Ranjit Akolekar, et al.. (2021). Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia. Circulation. 144(9). 670–679. 77 indexed citations
2.
Hobbs, Adrian J., Amie J. Moyes, Reshma S. Baliga, et al.. (2019). Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial. British Journal of Pharmacology. 176(9). 1251–1267. 19 indexed citations
3.
Athauda, Dilan, Kate Maclagan, Natalia Budnik, et al.. (2018). Post hoc analysis of the Exenatide‐ PD trial—Factors that predict response. European Journal of Neuroscience. 49(3). 410–421. 57 indexed citations
4.
Rolnik, Daniel L., D. Wright, Liona C. Poon, et al.. (2018). Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. Obstetrical & Gynecological Survey. 73(1). 11–12. 25 indexed citations
5.
Athauda, Dilan, Kate Maclagan, Kashfia Chowdhury, et al.. (2018). Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Yearbook of pediatric endocrinology. 9 indexed citations
6.
Tan, Min Yi, D. Wright, Argyro Syngelaki, et al.. (2018). Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound in Obstetrics and Gynecology. 51(6). 743–750. 251 indexed citations breakdown →
7.
Athauda, Dilan, Kate Maclagan, Natalia Budnik, et al.. (2018). What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis. Journal of Parkinson s Disease. 8(2). 247–258. 62 indexed citations
8.
Rolnik, Daniel L., D. Wright, Liona C. Poon, et al.. (2018). Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. Obstetric Anesthesia Digest. 38(1). 20–21. 11 indexed citations
9.
Athauda, Dilan, Kate Maclagan, Simon S. Skene, et al.. (2017). Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial. The Lancet. 390(10103). 1664–1675. 603 indexed citations breakdown →
10.
Rolnik, Daniel L., D. Wright, Liona C. Poon, et al.. (2017). Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. New England Journal of Medicine. 377(7). 613–622. 1372 indexed citations breakdown →
11.
Rolnik, Daniel L., D. Wright, Liona C. Poon, et al.. (2017). Aspirin versus Placebo in Pregnancies at High Risk of Preterm Preeclampsia. 3 indexed citations
12.
Maclagan, Kate. (2011). Anti-Müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 48(6). 586–586. 5 indexed citations
13.
Maclagan, Kate, Rita Tommasi, Emmanuelle Laurine, et al.. (2011). A Combinatorial Method to Enable Detailed Investigation of Protein–Protein Interactions. Future Medicinal Chemistry. 3(3). 271–282. 5 indexed citations
14.
Maclagan, Kate, Tam T. T. Bui, Bruno Pagano, et al.. (2010). Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights. Biochemical Journal. 427(2). 225–236. 27 indexed citations
15.
Reich, Stefanie, L. Puckey, Richard Harris, et al.. (2006). Combinatorial Domain Hunting: An effective approach for the identification of soluble protein domains adaptable to high‐throughput applications. Protein Science. 15(10). 2356–2365. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bjarne M. Iversen Breakdown of academic impact, for papers by Florian Herse Breakdown of academic impact, for papers by Jean St‐Louis Breakdown of academic impact, for papers by Chatarina Löfqvist Breakdown of academic impact, for papers by C.‐H. Bergh Breakdown of academic impact, for papers by Francisco Westermeier Breakdown of academic impact, for papers by Rainer Rossi Breakdown of academic impact, for papers by Diva D. De León Breakdown of academic impact, for papers by W M Wiersinga
Rankless by CCL
2026